As of 2026-01-09, the EV/EBITDA ratio of Thermo Fisher Scientific Inc (TMO) is 25.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TMO's latest enterprise value is 261,566.11 mil USD. TMO's TTM EBITDA according to its financial statements is 10,393.00 mil USD. Dividing these 2 quantities gives us the above TMO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 23.6x | 22.3x |
| Forward P/E multiples | 21.0x - 22.2x | 21.6x |
| Fair Price | 453.04 - 563.69 | 528.65 |
| Upside | -25.3% - -7.1% | -12.8% |
| Date | EV/EBITDA |
| 2026-01-07 | 25.55 |
| 2026-01-06 | 25.68 |
| 2026-01-05 | 25.34 |
| 2026-01-02 | 24.66 |
| 2025-12-31 | 24.19 |
| 2025-12-30 | 24.33 |
| 2025-12-29 | 24.39 |
| 2025-12-26 | 24.24 |
| 2025-12-24 | 24.18 |
| 2025-12-23 | 24.21 |
| 2025-12-22 | 24.05 |
| 2025-12-19 | 23.77 |
| 2025-12-18 | 23.57 |
| 2025-12-17 | 23.58 |
| 2025-12-16 | 23.85 |
| 2025-12-15 | 24.06 |
| 2025-12-12 | 23.93 |
| 2025-12-11 | 24.17 |
| 2025-12-10 | 23.99 |
| 2025-12-09 | 23.60 |
| 2025-12-08 | 23.78 |
| 2025-12-05 | 23.95 |
| 2025-12-04 | 24.04 |
| 2025-12-03 | 24.23 |
| 2025-12-02 | 24.22 |
| 2025-12-01 | 24.40 |
| 2025-11-28 | 24.60 |
| 2025-11-26 | 24.69 |
| 2025-11-25 | 24.85 |
| 2025-11-24 | 24.43 |
| 2025-11-21 | 24.48 |
| 2025-11-20 | 23.95 |
| 2025-11-19 | 23.99 |
| 2025-11-18 | 24.07 |
| 2025-11-17 | 23.75 |
| 2025-11-14 | 24.16 |
| 2025-11-13 | 24.21 |
| 2025-11-12 | 24.50 |
| 2025-11-11 | 24.44 |
| 2025-11-10 | 24.08 |
| 2025-11-07 | 23.94 |
| 2025-11-06 | 23.70 |
| 2025-11-05 | 23.76 |
| 2025-11-04 | 23.68 |
| 2025-11-03 | 23.66 |
| 2025-10-31 | 23.75 |
| 2025-10-30 | 23.35 |
| 2025-10-29 | 23.43 |
| 2025-10-28 | 23.40 |
| 2025-10-27 | 23.62 |